GlassScriptPhysician profile
Danielle R Collins
NPI 1255983888
$1,233.22
in general payments reported to CMS, 2019-2025
21 companies · $547 in 2025
The $547 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $237 · 2024: $450 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,233.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $195.95 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $134.83 | 2024-2025 | Airsupra |
| Novo Nordisk INC | $103.17 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $94.36 | 2024-2025 | Rexulti |
| Philips North America LLC | $86.96 | 2024-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck4) Mcot |
| Exact Sciences Corporation | $71.80 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $65.79 | 2024-2025 | Zepbound, Mounjaro |
| Beta Bionics, INC. | $56.99 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Edwards Lifesciences Corporation | $55.36 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Glaxosmithkline, LLC. | $47.63 | 2023-2025 | Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $45.29 | 2025 | Gardasil 9, Capvaxive |
| Abiomed | $42.64 | 2024 | Impella |
| Cleerly, INC. | $34.78 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Astellas Pharma US INC | $32.04 | 2024 | Veozah |
| Abbott Laboratories | $30.20 | 2025 | Freestyle Libre 3 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $28.57 | 2025 | Fluad, Flucelvax |
| Idorsia Pharmaceuticals US INC | $27.58 | 2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $20.75 | 2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $20.05 | 2025 | |
| Aimmune Therapeutics, INC. | $19.66 | 2025 | Zenpep |
| Dexcom, INC. | $18.82 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.